Drug Seeking Behavior in ER Doubles, Feeds Growing Addiction to Pain Pills -- Emergency rooms continue to become a major resource for pain medication addicts; By MIKAELA CONLEY, ABC News Medical Unit -- Oct. 28, 2010 » More
|
|
|
 |
Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter 8 Drivers Impacting Cost Savings Catasys Health - Thursday, September 23, 2010
Catasys On Healthcare September 2010 Newsletter Cutting Edge Treatment for Substance Dependence for Health Plans Catasys Health - Wednesday, December 16, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.
The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak: » More
Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence Catasys Health - Wednesday, November 25, 2009
Harold Urschel, Research Across America, Dallas, Texas Catasys Enters Into Agreement with Ford Motor Company Catasys Health - Thursday, September 17, 2009
LOS ANGELES--(BUSINESS WIRE) -- Sep. 17, 2009 --
Catasys, Inc. announced today that the Company has entered into a three
year agreement with Ford® Motor Company to provide the OnTrak
integrated substance dependence solution to Ford’s hourly employees in
Michigan enrolled in the National PPO and who meet certain criteria.
Eligible employees struggling with alcoholism, stimulant and opiate
dependence will be covered under the program, which contains medical
interventions, psychosocial therapy and care coaching components across
52 weeks. The Company will conduct direct outreach to enroll qualified
members, and will also work with UAW-Ford and Ford’s EAP program to
ensure the most beneficial treatment pathway for members. Contractual
revenues from the agreement are based on a combination of monthly fees
for the member population for Catasys, with additional monthly fees for
members enrolled into the Catasys program. Operational implementation is
expected to begin shortly, and the program is anticipated to launch in
the fourth quarter of 2009.
“We are pleased by the level of support we received from UAW-Ford and Ford’s management personnel,” said Rick Anderson, Catasys’ President and COO. “We have realigned our company and developed Catasys for the managed care market, and it is rewarding to have a new agreement that further publicly validates our product and business model. Ford’s desire to improve employee care and productivity demonstrates a significant opportunity for health plans to provide their customers the Catasys solution.” Various studies, research and other resources demonstrate that: » More Raymond Anton, Medical University of South Carolina, Charleston, SC Catasys Health - Saturday, August 01, 2009
Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
| 1 |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||
 |
|
||||||||||||||||